Literature DB >> 21817944

Management strategy of vestibular schwannoma in neurofibromatosis type 2.

Haitham Ahmad Odat1, Enrico Piccirillo, Giuliano Sequino, Abdelkader Taibah, Mario Sanna.   

Abstract

OBJECTIVES: To discuss our management strategy of vestibular schwannoma in patients with neurofibromatosis type 2 (NF2). STUDY
DESIGN: Retrospective study.
SETTING: Quaternary referral skull base center.
METHODS: Thirty-eight NF2 patients who had undergone 48 operations at the Gruppo Otologico between January 1988 and December 2008. The mean age at time of surgery was 36.3 years (range, 17-65 yr), and the average tumor size was 3.1 cm (range, 0.6-6 cm). There were 27 female and 21 male ears, and 25 cases were right side ears, whereas 23 were left sided. The average follow-up time was 3.7 years. Surgical approaches, hearing, and facial nerve functions, as well as hearing rehabilitation and facial nerve reconstruction outcomes, are discussed.
RESULTS: Total tumor resection was achieved in 44 cases (92%). Facial nerve function was postoperatively House-Brackmann grades I-III in 36 cases (77%); it was grade I in 17 cases (35%) and grade II in 8 cases (17%). In 7 cases, hearing preservation was attempted, and a measurable hearing has been recorded in 5 cases (71%). Auditory brainstem implant was inserted in 25 cases, and concomitant cochlear implants were inserted in 5 cases.
CONCLUSION: Early diagnosis and treatment of bilateral vestibular schwannoma in patients with NF2 will achieve the best outcomes regarding facial nerve, hearing preservation, and postoperative complications. The watchful waiting policy will decrease the chance of reaching these goals. Cochlear implants and auditory brainstem implant have made hearing rehabilitation possible in NF2 patients who had bilateral sensorineural hearing loss.

Entities:  

Mesh:

Year:  2011        PMID: 21817944     DOI: 10.1097/MAO.0b013e3182267f17

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  10 in total

1.  Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.

Authors:  Alessandro Cama; Fabio Verginelli; Lavinia Vittoria Lotti; Francesco Napolitano; Annalisa Morgano; Andria D'Orazio; Michele Vacca; Silvia Perconti; Felice Pepe; Federico Romani; Francesca Vitullo; Filippo di Lella; Rosa Visone; Massimo Mannelli; Hartmut P H Neumann; Giancarlo Raiconi; Carlo Paties; Antonio Moschetta; Roberto Tagliaferri; Angelo Veronese; Mario Sanna; Renato Mariani-Costantini
Journal:  Acta Neuropathol       Date:  2013-08-18       Impact factor: 17.088

Review 2.  [Magnetic resonance imaging in patients with magnetic hearing implants: overview and procedural management].

Authors:  S Nospes; W Mann; A Keilmann
Journal:  Radiologe       Date:  2013-11       Impact factor: 0.635

3.  Clinicopathologic assay of 15 tumor resections in a family with neurofibromatosis type 2.

Authors:  Salvatore Di Maio; Goran Mrak; Gordana Juric-Sekhar; Donald Born; Alessandra Mantovani; Laligam N Sekhar
Journal:  J Neurol Surg B Skull Base       Date:  2012-04

4.  Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation.

Authors:  Fu Zhao; Bo Wang; Zhijun Yang; Qiangyi Zhou; Peng Li; Xingchao Wang; Jing Zhang; Junting Zhang; Pinan Liu
Journal:  J Neurooncol       Date:  2018-02-28       Impact factor: 4.130

5.  Establishment of nomograms for the prediction of useful hearing loss in patients with neurofibromatosis type 2.

Authors:  Shi-Wei Li; Jing Zhang; Han-Lu Tang; Peng Li; Bo Wang; Fu Zhao; Pi-Nan Liu
Journal:  J Neurooncol       Date:  2021-11-09       Impact factor: 4.130

6.  Cochlear implant in vestibular schwannomas: long-term outcomes and critical analysis of indications.

Authors:  Flavia Sorrentino; Giulia Tealdo; Diego Cazzador; Niccolò Favaretto; Davide Brotto; Silvia Montino; Ezio Caserta; Roberto Bovo; Luca Denaro; Valentina Baro; Domenico D'Avella; Alessandro Martini; Antonio Mazzoni; Gino Marioni; Elisabetta Zanoletti
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-12       Impact factor: 3.236

7.  Cochlear Implantation in Vestibular Schwannoma: A Systematic Literature Review.

Authors:  Kent Tadokoro; Matthew Robert Bartindale; Nadeem El-Kouri; Dennis Moore; Christopher Britt; Matthew Kircher
Journal:  J Neurol Surg B Skull Base       Date:  2021-06-08

8.  Clinical outcome of neurofibromatosis type 2-related vestibular schwannoma: treatment strategies and challenges.

Authors:  Byung Sup Kim; Ho Jun Seol; Jung-Il Lee; Hyung Jin Shin; Kwan Park; Doo-Sik Kong; Do-Hyun Nam; Yang-Sun Cho
Journal:  Neurosurg Rev       Date:  2016-05-04       Impact factor: 3.042

9.  Microsurgery for patients diagnosed with neurofibromatosis type 2 complicated by vestibular schwannomas: Clinical experience and strategy for treatments.

Authors:  Li-Hua Chen; Hong-Tian Zhang; Ru-Xiang Xu; Li Zhang; Wen-De Li; Kai Sun
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

10.  [18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.

Authors:  Jose M Anton-Rodriguez; Daniel Lewis; Ibrahim Djoukhadar; David Russell; Peter Julyan; David Coope; Andrew T King; Simon K L Lloyd; D Gareth Evans; Alan Jackson; Julian C Matthews
Journal:  Otol Neurotol       Date:  2019-07       Impact factor: 2.311

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.